Patient Enrollment Advisors and Cambridge Healthtech Institute Announce the 10th Annual Participant Engagement Award Is Now Open for Submissions

Winners to be announced at SCOPE 2026 in Orlando

NEW YORK, Sept. 18, 2025 /PRNewswire/ -- Patient Enrollment Advisors, in collaboration with Cambridge Healthtech Institute, announces that the 10th Annual Participant Engagement Award is now open for submissions. The deadline to enter is October 31, 2025. The finalists will present on stage, and a winner will be announced at the Summit for Clinical Operation Executives (SCOPE) on February 2, 2026, in Orlando, Florida.

The competition welcomes submissions from across the entire life science ecosystem— including sponsors, contract research organizations, research sites, agencies, patient advocacy groups, and start-ups. Entries will be evaluated based on creativity, innovation, regulatory compliance, and impact on trial access and participation. Finalists will be invited to present their work live on stage at the SCOPE Summit.

To learn more and apply click here.

The Participant Engagement Award recognizes outstanding innovation and creativity in communication strategies for clinical trials, emphasizing programs that successfully recruit, engage, and retain study participants. Established in memory of Jerry Matczak, who received the inaugural award, this honor continues to be inspired by his passion for patient engagement.

"When I co-created this concept with Kelly McKee with the support of Micah Lieberman of CHI, our goal has been to celebrate bold ideas and meaningful connections that transform participation in clinical trials," said David Sall, CEO and Founder of Patient Enrollment Advisors. "Reaching the 10-year milestone reflects the ongoing dedication and innovative spirit of our industry to keep patients at the heart of clinical research."

About Patient Enrollment Advisors
Patient Enrollment Advisors (PEA) is a global leader in patient recruitment and retention solutions for clinical trials. With extensive experience, PEA partners with sponsors, research organizations, and clinical sites to improve trial access, speed enrollment, and keep participants engaged throughout the study process.

Press Contact:
Maximum Exposure PR
917-414-1396
[email protected] 

SOURCE Patient Enrollment Advisors